Positron Corporation announced it has secured exclusive rights for the North American market to sell/distribute the NeuSight PET-CT 64 slice scanner through a business cooperation agreement with Shenyang Intelligent Neuclear Medical Technology Co. The NeuSight PET- CT 64 slice scanner is an award-winning top performing scanner with installations throughout the world. NeuSight PET-ct 64 has FDA clearance to be marketed and sold in the United States which Positron will introduce and sell to the nuclear cardiac imaging market in July 2024.

The NeuSightPET-CT 64 slice is an innovative, economical, PET-CT system which is ideal for clinical exploration, data acquisition and identification technology for improved scanning speed and accuracy. The NeuSight Pet-CT system provides anatomic and functional imaging with qualified designs and technology. The NeuSight system serves multiple molecular imaging functions for heart, tumor, and brain imaging studies.